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Abstract
We have determined the X-ray crystal structures of the NADH-dependent alcohol dehydrogenase
LlAdhA from Lactococcus lactis and its laboratory-evolved variant LlAdhARE1 at 1.9 Å and 2.5 Å
resolution, respectively. LlAdhARE1, which contains three amino acid mutations (Y50F, I212T,
and L264V), was engineered to increase the microbial production of isobutanol (2-
methylpropan-1-ol) from isobutyraldehyde (2-methylpropanal). Structural comparison of LlAdhA
and LlAdhARE1 indicates that the enhanced activity on isobutyraldehyde stems from increases in
the protein’s active site size, hydrophobicity, and substrate access. Further structure-guided
mutagenesis generated a quadruple mutant (Y50F/N110S/I212T/L264V), whose KM for
isobutyraldehyde is ~17-fold lower and catalytic efficiency (kcat/KM) is ~160-fold higher than
wild-type LlAdhA. Combining detailed structural information and directed evolution, we have
achieved significant improvements in non-native alcohol dehydrogenase activity that will facilitate
the production of next-generation fuels such as isobutanol from renewable resources.
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1. Introduction
Alcohol dehydrogenases (ADH, EC 1.1.1.1) are oxidoreductases that catalyze the reversible
oxidation of a wide range of alcohols to the corresponding aldehydes or ketones using
nicotinamide adenine dinucleotides (NAD(P)H) as coenzymes. Ubiquitous in bacteria, yeast,
plants, and mammals, ADHs can be divided into three classes based on size (Reid et al.,
1994): short-chain ADHs (c.a. 250 residues), long- chain, iron-activated ADHs (c.a. 385
residues), and medium-chain, zinc-dependent ADHs (c.a. 350 residues) which also belong to
the medium-chain dehydrogenase/reductase (MDR) super-family. Several MDR-ADHs have
been structurally characterized, including horse liver ADH (HLADH, Eklund et al., 1976,
2008) and yeast Saccharomyces cerevisiae ADH (YADH, Leskovac et al., 2002). MDR-
ADHs are either dimeric or tetrameric. Dimeric ADHs are usually found in plants and
mammals, whereas tetrameric ADHs are mostly found in bacteria and yeast. The MDR-
ADH catalytic mechanism was established through studies of HLADH (Ramaswamy et al.,
1994; Agarwal et al., 2000) and supplemented by studies of related MDR-ADHs (Eklund
and Ramaswamy, 2008; Bakera et al., 2009).
ADHs play important roles in numerous natural and engineered metabolic pathways. The
latter includes the work of Liao and coworkers, who engineered Ehrlich and valine
biosynthetic pathways to produce isobutanol, a next-generation biofuel, in E. coli (Atsumi et
al., 2008). Liao’s isobutanol pathway diverts 2-ketoisovalerate, a valine precursor, to
isobutanol by over-expression of a 2-ketoisovalerate decarboxylase and an ADH. The ADH
catalyzes the final step, conversion of isobutyraldehyde to isobutanol. This pathway can be
used to produce isobutanol in a variety of microorganisms including E. coli (Atsumi et al.,
2008, 2009 and 2010; Cann and Liao, 2008; Shen and Liao, 2008; Connor and Liao, 2009;
Savrasova et al., 2011; Baez et al., 2011), Corynebacterium glutamicum (Smith et al., 2010;
Blombach et al., 2011), Bacillus subtilis (Li et al., 2011), and Clostridium cellulolyticum
(Higashide et al., 2011). Atsumi and coworkers reported that the NADH-dependent AdhA
from Lactococcus lactis (LlAdhA) functions in this pathway, as does an NADPH-dependent
homologue, YqhD, that is native to E. coli (Atsumi et al., 2010). Although the KM of YqhD
toward isobutyraldehyde is 5-fold lower than that of LlAdhA, its preference for NADPH
over NADH generates an overall cofactor imbalance in the biosynthetic pathway. To relieve
the cofactor imbalance and improve isobutanol production, Bastian and coworkers in this
laboratory used directed evolution by sequential rounds of random mutagenesis and
screening to enhance L1AdhA activity on isobutyraldehyde (Bastian et al., 2011). The
resulting ADH variant, LlAdhARE1, contained three amino acid substitutions (Y50F, I212T,
and L264V) that led to a ~7-fold decrease in KM and a ~30-fold increase in catalytic
efficiency (kcat/KM) over wild- type LlAdhA. Inclusion of LlAdhARE1 in the isobutanol
biosynthetic pathway in place of wild-type LlAdhA increased anaerobic isobutanol titer
from 8.4 g/L to 13.4 g/L in a 24-hour fermentation (Bastian et al., 2011).
To better understand the activity enhancements in LlAdhARE1 and to guide further
mutagenesis to decrease the KM for isobutyraldehyde, a non-native substrate of LlAdhA, we
determined the crystal structures of LlAdhA and LlAdhARE1. We have used the structures to
further improve LlAdhARE1 for this pathway and provide insights into how these
improvements were achieved.
2. Materials and methods
2.1 General
Strains, plasmids and primers are listed in Tables S1 and S2, Supplemental Information.
Biological media were purchased from Research Products International (Mt. Prospect, IL,
USA), NADH from Codexis, Inc. (Redwood City, CA, USA), aldehydes from Sigma-
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Aldrich (St. Louis, MO, USA), oligonucleotides from Integrated DNA Technologies (San
Diego, CA, USA), DNA polymerases, restriction enzymes, and T4 ligase from New England
Biolabs (Ipswich, MA, USA). DNA sequencing was performed by Laragen (Los Angeles,
CA, USA). Standard molecular biology methods were taken from Maniatis et al. (Sambrook
et al., 1989).
2.2 Cloning, library construction, and heterologous expression
For crystallization purposes, the genes encoding LlAdhA and variant LlAdhARE1 were
cloned into pET22b(+) (EMD Chemicals Group, Darmstadt, Germany) using NdeI and XhoI
restriction sites as described previously (Bastian et al., 2011) and expressed in E. coli
BL21(DE3). Plasmids pGVRE1 and pGV29C8 harboring variants LlAdhARE1 and
LlAdhA29C8 served as templates for site-saturation mutagenesis and random mutagenesis
library construction, respectively. The libraries were constructed using primers listed in
Table S2, Supplemental Information, and expressed in yeast CEN.PK2 as described
previously (Bastian et al., 2011). Mutant LlAhdARE1-T212I harboring only the Y50F and
L264V mutations was constructed using plasmid pGVRE1 and primers RE1_T212I for and
RE1_T212I_rev (Table S2, Supplemental Information).
2.3 Kinetic assay and high-throughput screening
ADH activities were detected by monitoring NADH consumption at 340 nm for
isobutyraldehyde, acetaldehyde, and coniferaldehyde, and at 365 nm for 2-furaldehyde,
hydroxymethylfurfural (5-HMF), cinnamaldehyde, 4-hydroxybenzaldehyde, syringaldehyde
and vanillin, as described previously (Larroy et al., 2002). All variants were purified by
immobilized metal affinity chromatography (IMAC) before they were assayed. High-
throughput screening was conducted using yeast lysate as described previously (Bastian et
al., 2011).
2.4 Thermostability measurements
To determine the half-denaturation temperature (T50) of LlAdhA and its variants, 30- µL
aliquots of purified enzyme were transferred into PCR tubes. Each tube was assigned a
specific incubation temperature that corresponded to a slot on the block of an Eppendorf
master cycler PCR machine programmed with a gradient covering a 20°C temperature
range. The measurements were conducted in duplicate. The temperature range was changed,
depending on the stability of the tested enzymes, in order to cover the denaturation range.
The tubes were incubated in their slots for 15 min, and the reactions were then quenched on
ice. Residual activity was determined with the activity assay in a total volume of 100 µL in a
plate reader (TECAN Group Ltd., Switzerland). T50 is defined as the temperature at which
50% of the initial activity is retained after 15 minutes incubation.
2.5 Protein purification, crystallization, and data collection
Wild-type LlAdhA and variants LlAdhARE1 and LlAdhARE1-T212I were expressed from
pET22b(+) in E. coli BL21(DE3) and purified by IMAC as described (Bastian et al., 2011).
For crystallization purposes, the IMAC-purified proteins were subjected to two sequential
anion exchange chromatography runs over pre-equilibrated Q Sepharose™ columns
(HiTrap™ Q HP, GE Healthcare, Piscataway, NJ, USA) using an AKTA FPLC system (GE
Healthcare, Waukesha, WI, USA) after a buffer exchange to buffer A (25 mM Tris pH 7.4,
and 10 mM MgCl2). The anion exchange purification method consisted of a 4-column
volume equilibration step with buffer A, followed by sample injection and washout of
unbound sample with buffer A for two column volumes. The proteins were eluted with a
linear gradient from buffer A to 100% buffer B (25 mM Tris pH 7.4, 10 mM MgCl2, and 1
M NaCl) over 10 column volumes. Both enzymes eluted at 35% buffer B. Purified proteins
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(>99% purity) were then subjected to a buffer exchange to TBS buffer (50 mM Tris pH 7.4
and 150 mM NaCl) and concentrated to 12 mg/mL prior to crystallization. For determination
of the oligomerization state, we performed size exclusion chromatography on a Superdex™
200 10/300 GL column (GE Healthcare) with 20 mM Tris, pH 7.0. Prior to the gel filtration,
the enzyme was purified over a HisTrap column as described above followed by a
concentration step using centrifugal filter units with a 30 kDa MWCO (Millipore). The
column was calibrated with gel filtration standards from Bio-Rad. Droplets (0.3 µL) of
concentrated protein solutions were tested against an equal volume of 480 crystallization
conditions at room temperature using the sitting drop method. The first hit appeared in 30%
(v/v) polyethylene glycol 400, 0.2 M calcium acetate, 0.1 M sodium acetate pH 4.5 for
LlAdhARE1 and was further refined by traditional methods employing the sitting drop
method in Linbro plates (Hampton Research). The final crystallization conditions were 30%
(v/v) polyethylene glycol 400, 0.2 M calcium acetate, 0.1 M sodium acetate pH 4.5 for
LlAdhARE1, and 30% (v/v) polyethylene glycol 400, 0.2 M calcium acetate, 0.1 M sodium
acetate pH 5.0 for LlAdhA, and both yielded crystals in two days.
Crystals were transferred into a cryoprotectant solution of mother liquor supplemented with
25% (v/v) PEG 400 prior to flash-cooling in liquid nitrogen and shipping to the Stanford
Synchrotron Radiation Laboratory (SSRL). Diffraction data were collected using a Dectris
Pilatus 6M detector on beamline 12-2 at SSRL at 100 K. An X-ray wavelength of 0.954 Å
was used for both proteins. Diffraction datasets were integrated with XDS (Kabsch, 2010)
and scaled using SCALA (Evans, 2006).
2.6 Molecular replacement and structural refinement
The crystal structure of LlAdhARE1 was determined by molecular replacement. First, a
homology model for LlAdhARE1 from a variety of available homologous structures was
generated using MODELLER (Šali et al., 1995). The program MOLREP (Vagin and
Teplyakov, 1997) in CCP4 (Bailey, 1994) was then used to identify a candidate solution in
which two monomers form a contiguous beta sheet via residues 280–285. However this
solution was not amenable to refinement (rigid REFMAC Rfree = 0.52). This solution was
somewhat improved (Rfree = 0.39) by PHENIX Autobuild (Adams et al., 2010). To proceed,
we removed large portions (~40%) of the model, deleting most of the ill-fitting Rossmann
domains. This truncated model retained an Rfree of 0.4 after applying PHENIX Refine.
Given this model, a subsequent Autobuild run produced an entirely different dimer interface
(via residues 97–100) with an improved Rfree of 0.34. At this point, the density map was of
sufficient quality to manually rebuild missing segments of the model in Coot (Emsley and
Cowtan, 2004), leading to a productive iterative cycle between manual refinement in Coot
and automated refinement using PHENIX. The structure of wild-type LlAdhA was
determined using the LlAdhARE1 model.
2.7 Structure analysis and modeling
The crystal structure of LlAdhA was superimposed with the crystal structures of variant
LlAdhARE1, Bacillus stearothermophilus ADH (htADH, PDB ID: 1RJW, 50% identity)
(Ceccarelli et al., 2004) and Pseudomonas aeruginosa ADH (PaADH, PDB ID: 1LLU, 41%
identity) (Levin et al., 2004) on Cα atoms using the align tool within Pymol (The PyMOL
Molecular Graphics System, Version 1.2r3pre, Schrödinger, LLC). Root mean square
deviation (rmsd) values were obtained by Pymol using the align tool. NADH coordinates
were extracted from PaADH after superposition of PaADH with LlAdhA and were used to
model NAD+ into LlAdhA and LlAdhARE1. Isobutanol was built into LlAdhA and
LlAdhARE1 structures manually using trifluoroethyl alcohol from htADH as a starting
model.
Liu et al. Page 4
J Biotechnol. Author manuscript; available in PMC 2013 December 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
2.8 Protein Data Bank accession codes
Coordinates and structure factors have been deposited in the Protein Data Bank with
accession numbers 4EEX for LlAdhA and 4EEZ for LlAdhARE1.
3. Results and Discussion
3.1 Crystal structures of LlAdhA and variant LlAdhARE1
We determined the crystal structures of LlAdhA and variant LlAdhARE1 to understand the
basis of the activity increase in the variant and to obtain guidance for further enzyme
engineering. This work provides the first structure of an ADH from L. lactis. The
crystallographic statistics for LlAdhA and LlAdhARE1 data collection and refinement are
shown in Table 1. Both crystal structures were observed in space group C2221 with two
molecules per asymmetric unit. Size exclusion chromatography revealed only a peak
consistent with dimer formation (see Methods). The observed dimer is likely to correspond
either to the two monomers found in the crystallographic asymmetric unit (~1830 Å2 buried)
or to a crystallographic dimer formed via beta strand pairing of the Rossmann domain
(~3450 Å2 buried). Most bacterial ADHs are tetrameric, and LlAdhA represents a rare
dimeric bacterial ADH. The LlAdhARE1 structure was determined by molecular
replacement, and the structure of wild-type LlAdhA was determined using LlAdhARE1 as a
starting model. LlAdhA and LlAdhARE1 were refined to an Rfree of 23.0% and 20.4% at a
resolution of 2.2 Å and 1.9 Å, respectively.
Structural alignment of LlAdhA and LlAdhARE1 resulted in a root mean square deviation
(rmsd) of 0.19 Å, indicating the absence of large-scale structural changes attributable to the
mutations. We do observe structural differences between asymmetric monomers within both
LlAdhA and LlAdhARE1 crystal structures. For example, the rmsd between chains A and B
of LlAdhARE1 is 1.36 Å. Alignment of these structures with an NADH-bound structure of
the alcohol dehydrogenase from Pseudomonas aeruginosa (PaADH, PDB ID: 1LLU) shows
that in both cases the tertiary structure of chain A in LlAdhA and its variant closely
resembles the cofactor- bound protein (rmsd = 0.81 Å). Chain B (rmsd = 1.83 Å) shows
considerable differences in the cofactor-binding domain. It is known that cofactor binding in
other ADHs induces conformational changes in this region (Plapp, 2010). Together, these
data suggest that the LlAdhA crystal packing permits both open and closed conformations to
be observed, even in the absence of the bound reductant.
The LlAdhA monomer (Fig. 1) comprises 339 residues and contains two zinc ions, a
structural zinc and a catalytic zinc. The structural zinc is tetrahedrally coordinated by four
cysteine residues (Cys91, Cys94, Cys97, and Cys105). In LlAdhA, coordination of the
catalytic zinc is consistent with most MDR-ADHs and involves active site amino acids
Cys39, His60, and Cys147. The fourth coordination site is filled by a water molecule in the
substrate/cofactor-free enzyme subunit (Aulda and Bergman, 2008).
Each LlAdhA monomer contains two distinct domains: a coenzyme-binding domain, which
folds into a classical α/β Rossmann fold (residues 148–287), and a catalytic domain
(residues 1–147 and 288–339). These two domains are connected by an interdomain ‘hinge’
formed by a helix (residues 148–159) and a loop (residues 285- 291), and are separated by a
deep cleft that houses the active site and the catalytic zinc. LlAdhA contains a conserved
proton relay system composed of Thr41 and His44; this system contributes to the transfer of
protons to free solvent, which serves as a driving force for catalysis (Agarwal et al., 2000;
Levin et al., 2004).
To identify molecular determinants of NADH cofactor binding, we superposed the LlAdhA
and the NADH-bound PaADH structures (Levin et al., 2004). From this alignment, we infer
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that the cofactor interacts with LlAdhA through a number of hydrogen bonds with the
protein main chain (residues Val262, Ser286, Val288, Leu264, His40, Leu175, and Gly174)
as well as several amino acid side chains (residues His44, Thr41, His40, Asp195, and
Arg333) (see Fig. 2). Asp195 is conserved throughout all NADH-dependent ADHs for
recognition of the two NADH ribosyl hydroxyl groups. The conserved Rossmann GxGxxG
motif is also observed in LlAdhA.
3.2 Protein engineering of LlAdhA to increase activity on isobutyraldehyde
LlAdhA catalyzes the final step, reduction of isobutyraldehyde, in the engineered
biosynthesis of isobutanol (Atsumi et al., 2008 and 2010; Bastian et al., 2011). To improve
isobutanol production by this novel pathway, we previously used directed evolution to
enhance the catalytic efficiency of LlAdhA for isobutyraldehyde. Random mutagenesis and
subsequent recombination of beneficial mutations yielded variant LlAdhARE1 with a ~7-fold
decrease in KM and ~30-fold increase in catalytic efficiency on isobutyraldehyde (Table 2,
Bastian et al., 2011). Attempts to further improve activity by random mutagenesis were
unsuccessful. Using the LlAdhARE1 structure, we selected four residues based on their
proximity to the substrate binding pocket, Trp86, Asn110, Leu287, and Val288, for
saturation mutagenesis with the gene coding for RE1 as template. Upon screening the four
individual libraries to >95% coverage we identified a variant with the additional N110S
mutation. This variant, LlAdhA29C8, has a ~17-fold decrease in KM (from 12 to 0.68 mM)
and a ~160-fold increase in catalytic efficiency (from 2.8 to 440 mM−1s−1) on
isobutyraldehyde compared to wild-type LlAdhA (Table 2). No improved variants were
isolated from the saturation mutagenesis at residues Trp86, Leu287, or Val288.
3.3 Structural insights into directed evolution
3.3.1 Structural basis of the increased activity of LlAdhARE1 on
isobutyraldehyde—Three mutations (Y50F, I212T, and L264V) present in LlAdhARE1
are responsible for its ~30-fold higher catalytic efficiency on isobutyraldehyde. Mutation
I212T is surface-exposed in the NADH-binding domain of LlAdhARE1 and distant from the
active site. Because this mutation was discovered together with Y50F (Bastian et al., 2011),
we constructed the variant having only the Y50F and L264V mutations, denoted
LlAdhARE1-T212I, and compared its activity to that of LlAdhARE1 (Table 2);
LlAdhARE1-T212I has a significantly lower kcat. I212T thus makes an important contribution
to the increased activity, despite its location >20 Å from the active site.
Mutations L264V and Y50F lie in loops that cap the active site and have a more direct role
in regulating activity on isobutyraldehyde (Fig. 3A). Making use of the known structure of
zinc-bound trifluoroethanol (see Methods), we modeled zinc-bound isobutanol in the active
site of LlAdhARE1 using Pymol (Fig. 3A). From this model, it is apparent that the wild-type
Leu264 side chain leaves little space for the bulky terminal methyl groups of
isobutyraldehyde or isobutanol. We suspect that mutation to the smaller valine provides the
space to accommodate the non-native aldehyde, which is larger than the native substrate,
acetaldehyde. Deletion of the Tyr hydroxyl in Y50F, which packs against the side chain of
Leu264 in wild-type LlAdhA, further enlarges the substrate-binding pocket to accommodate
larger substrates. Analogous mutations that increase the size and hydrophobicity of the
active site cavity have been found in the yeast homolog YADH-1 (Murali and Creaser,
1986; Creaser et al., 1990). Moreover, replacement of Trp54 in YADH-1 (analogous to
Tyr50 in LlAdhA) with leucine was found to broaden substrate specificity (Weinhold et al.,
1995). Thus we propose that improvements in isobutyraldehyde activity in LlAdhARE1 are
due to its enlarged and increasingly hydrophobic binding pocket resulting from loss of the
Tyr50 hydroxyl moiety and substitution of bulky Leu264 with valine (Fig. 3A, Table 3).
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The entrance to the LlAdhA active site is formed by the side chains of four residues: Tyr50,
Trp86, Leu264, and Leu287. In LlAdhARE1, shortening of the leucine side chain in L264V
leads to significant opening of the entrance (Fig. 3B). It has been shown that the loop 292–
299 in the horse liver enzyme HLADH, which corresponds to the loop containing Leu264 in
LlAdhA, undergoes conformational changes upon cofactor binding (Plapp, 2010). Similar
conformational changes are expected to be important in LlAdhA, and mutations in this loop
will tune substrate binding and catalysis. We observe very subtle movements of the loop
carrying Phe50 versus Tyr50 (the alpha carbon moves only 0.3 Å when residues 40–60 are
aligned). As shown in Fig. 3B, the overall effect is greater substrate access that leads to the
ADH catalytic zinc center. Therefore, improvements in the activity of LlAdhARE1 on
isobutyraldehyde can be attributed to expansion and increased hydrophobicity of the
substrate-binding pocket combined with improved substrate access to the active site.
3.3.2 Effects of N110S on isobutyraldehyde activity in LlAdhA29C8—If Leu264
and Tyr50 form one wall of the substrate pocket, the opposing wall comprises Leu287,
Val288, Trp86, and Asn110. We carried out site-saturation mutagenesis at each of these
sites and found one favorable mutation, N110S. We can only speculate on the effect of this
mutation since the structure of LlAdhA29C8 is not available. However, it is likely that the
N110S mutation perturbs the conformation of Trp86, which in turn affects the substrate
binding pocket. In most bacterial ADHs the side chain of Asn110 pi-stacks with the indole
ring of the highly conserved Trp86, which lies just above the catalytic zinc. The increased
activity of LlAdhA29C8 may be due to a subtle, or even dramatic, reorientation of the Trp86
indole ring. For example, the N110S mutation could allow the indole ring to flip, which
would significantly open the substrate channel.
Site-saturation mutagenesis of residues 86 and nearby 287 and 288 yielded no improved
mutants. Residues Leu287 and Val288 are located in a loop that connects the two protein
sub-domains and might be involved in the closing of the active site during cofactor binding
(Colonna-Cesari et al., 1986; Hayward and Kitao, 2006). The side chain of Trp86 lies in the
active site cavity; it is notable that Trp86 is conserved in almost all MDR-ADHs. Studies of
Trp86 in thermophilic SsADH suggest a critical role in governing substrate specificity
(Pennacchio et al., 2009). We propose that the lack of improved variants in libraries
targeting Trp86, Leu287, and Val288 is due to the essential roles played by these side
chains.
3.3.3 Thermostability changes during evolution—We were also interested in the
stabilities of the LlAdhA variants, as stability is considered a determinant of the capacity of
a lineage to evolve (Vendruscolo et al., 1997; Kirschner and Gerhart, 1998; Bornberg-Bauer
and Chan, 1999; O’Loughlin et al., 2006). We therefore measured thermostabilities in terms
of T50, the temperature at which 50% of the initial activity is retained after 15 minutes
incubation. Decreases in (thermo)stability often accompany mutations that increase/alter
protein activity during directed evolution (Shoichet et al., 1995; Tokuriki et al., 2008). The
T50 of variant LlAdhARE1, however, is approximately 7°C higher than that of wild-type
LlAdhA (Table 2). One underlying cause for the increase in stability is likely to be the
removal of solvent-exposed hydrophobic groups. The increased thermostability associated
with I212T could result from a reduced propensity for protein aggregation; this mutation
removes several surface-exposed hydrophobic atoms from an edge-exposed beta strand.
Similarly, the L264V mutation removes an additional solvent-exposed hydrophobic
methylene as well as increasing beta-sheet propensity (Muñoz and Serrano, 1994; Street and
Mayo, 1999). Introduction of the N110S mutation in LlAdhA29C8 reduces T50 back to the
wild-type level (Table 2). We hypothesize that the destabilizing effect of N110S reflects
changes in orientation of the active site Trp86 aromatic ring (as discussed above).
LlAdhA29C8 is as stable as wild-type LlAdhA, and decreased stability cannot account for
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our inability to obtain further activity improvements by directed evolution (Bloom et al.,
2006; Tokuriki and Tawfik, 2009).
3.3.4 Substrate specificity changes during directed evolution—The mutations
selected during directed evolution reshape the substrate-binding pocket to favor
isobutyraldehyde binding and catalysis. We suspected that changes in substrate specificity
might reflect a general increase in ADH activity on larger substrates, as such substrate
‘promiscuity’ is often observed during directed evolution for activity on novel substrates
(Roodveldt and Tawfik, 2005; Fasan et al., 2008). To investigate this, we tested the ADHs in
the evolutionary lineage for activity against a panel of substrates and inhibitors, including
acetaldehyde as well as other aldehydes that are biologically produced and inhibit cell
growth during the fermentative processes of alcohol-producing microorganisms (Klinke et
al., 2004). A summary of the kinetic parameters of LlAdhA, LlAdhARE1, and LlAdhA29C8
for different aldehydes is listed in Table 3. Neither the variants nor wild-type LlAdhA
exhibited detectable activity on 4-hydroxybenzaldehyde, syringaldehyde, vanillin, or
coniferaldehyde under standard assay conditions. Wild-type LlAdhA exhibited high activity
on acetaldehyde, cinnamaldehyde, and 2-furaldehyde, with catalytic efficiencies of 94
mM−1s−1, 39 mM−1s−1, and 57 mM−1s−1, respectively, but showed low activity for
isobutyraldehyde and hydroxymethylfurfural (5-HMF) (2.8 mM−1s−1 and 0.88 mM−1s−1,
respectively). Directed evolution from LlAdhA to LlAdhA29C8 significantly decreased KM
values for 5-HMF and isobutyraldehyde: the 5-HMF KM decreased ~38-fold, from 22 mM
to 0.57 mM, and the isobutyraldehyde KM decreased ~17-fold, from 12 mM to 0.68 mM.
Although enlarging the substrate-binding pocket facilitates access to other bulky substrates
similar in size to isobutyraldehyde, the increase in kcat is specific for isobutyraldehyde
(Table 3).
4. Conclusion
Two new crystal structures of ADHs from the medium-chain dehydrogenase/reductase
superfamily, LlAdhA and its evolved variant LlAdhARE1, were determined at high
resolution. Using structure-guided saturation mutagenesis, we were able to further engineer
LlAdhA to obtain an overall ~17-fold decrease in KM and a ~160-fold increase in catalytic
efficiency toward isobutyraldehyde. Structural analysis and substrate profiling showed that
the increased activity is accompanied by enlargement and increased hydrophobicity of the
substrate-binding pocket as well as widening of the channel that provides access to the
active site for bulky aldehyde substrates. Structure-guided saturation mutagenesis of key
binding pocket residues and screening for improved function can identify beneficial
mutations, which can be accumulated in iterative rounds, by recombination, or upon
simultaneous mutagenesis at multiple positions. These approaches can rapidly optimize
alcohol dehydrogenases, which are important catalysts in engineered pathways for
producing fuels and chemicals.
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Highlights
• The crystal structures of L. lactis alcohol dehydrogenase LlAdhA and its variant
were determined at high resolution.
• The structure helped guide engineering of a new variant with lower KM and
higher catalytic efficiency.
• Increases in active site size, hydrophobicity, and substrate access lead to
enhanced activity on isobutyraldehyde.
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Fig. 1.
The LlAdhA asymmetric unit dimer with catalytic domains (blue, light blue), Rossmann
fold (orange, yellow), structural zinc atoms (white spheres), and catalytic zinc atoms (black
spheres).
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Fig. 2.
The cofactor-binding site of LlAdhA (green), with cofactor coordinates adopted from the
superimposed NADH (orange) co-crystal structure of PaADH (PDB ID: 1LLU). Hydrogen
bonds to the main chain of residues Gly174, Leu175, Val262, Leu264, Ser286, and Val288
anchor NADH to the active site. The other hydroxyl groups are bound to the protein via a
series of amino acids, Thr41, His40, His44 Asp195, Lys200, and Arg333.
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Fig. 3.
(A) The active site of LlAdhA (orange) superimposed with LlAdhARE1 (green). The
catalytic zinc is shown as a blue sphere. Selected active site residues are shown in stick
form. Thr41 and His44 are implicated in the proton conduction pathway from the active site
to solvent. Isobutanol (white) and NAD+ (magenta) were modeled by alignment of htADH
and PaADH (see Methods), respectively. (B) Surface representation of LlAdhA (orange) and
LlAdhARE1 (green) active site cavities reveals an enlarged channel opening in LlAdhARE1’s
that may result in improved access of larger non-native substrates to the active site.
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Table 1
Crystallographic data collection and refinement statistics.
Crystal Parametersa LlAdhA
PDB ID 4EEX
LlAdhARE1
PDB ID 4EEZ
Space group C2221 C2221
Unit cell dimensions a=123.5 Å, a=124.4 Å,
b=126.5 Å, b=126.5 Å,
c=94.35 Å, c=94.2 Å,
α=β=γ=90° α=β=γ=90°
Data collection statistics
Wavelength 0.954 0.954
Resolution (Å) 2.2–32.2 (2.2–2.3)b 1.9–37.8 (1.9–2.0)
Total reflections 119805 193087
Unique reflections 34501 54325
Rmerge (%) 6.4 (43.1) 5.2 (31.5)
Completeness (%) 96.6 (92.8) 97.7 (97.2)
I/σ I 11.9 (2.8) 13.8 (3.3)
Refinement
Rfactor /Rfreec(%) 18.1/23.6 16.6/20.8
Protein molecules in asymmetric unit 2 2
No. of residues 680 681
No. of water molecules 188 435
No. of zinc atoms 4 4
Average B-factor (Å2)
Protein 32.3 24.4
Water 32.3 30.4
Geometry deviation
Rmsd on bond length (Å) 0.02 0.03
Rmsd on bond angles (deg) 1.81 1.99
Ramachandran analysis (%)
Preferred regions 97.9 98.1
Outliers 0.1 0.1
aAll data sets were collected from single crystals.
b
Highest-resolution shell is shown in parentheses.
cRfree is calculated using 5% of the reflections randomly excluded from refinement.
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